:::

詳目顯示

回上一頁
題名:International Scientific Productivity on Second-generation Antipsychotic Drugs in Taiwan: A Bibliometric Study
書刊名:Taiwanese Journal of Psychiatry
作者:López-Muñoz, Francisco沈武典Moreno, RaquelMolina, Juan D.Noriega, ConchaPérez-Nieto, Miguel A.Rubio, GabrielÁlamo, Cecilio
作者(外文):Shen, Winston W.
出版日期:2012
卷期:26:2
頁次:頁114-129+146
主題關鍵詞:第二代抗精神病劑非典型抗精神病劑書目計量學雙極性疾患臺灣Second-generation antipsychoticsAtypical antipsychoticsBibliometryBipolar disorderTaiwan
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(1) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:1
  • 共同引用共同引用:2
  • 點閱點閱:26
背景:這是一個關於台灣發表與第二代(非典型)抗精神病劑的(SGAs)相關文章的書目計量學研究。方法:利用EMBASE及MEDLlNE資料庫,我們選擇了所有發表自台灣,內容描述中包括非典型*、抗精神病劑*、SGAs*、clozapine等的文章。我們使用書目計量學中,關於產量及離散性(dispersion)的指標,分別使用Price定律,及Bradford定律。我們同時也計算了不同國家的參與度指數,並將部分台灣社會及健康資料與本書目計量學的研究結果做相關性的研究。結果:我們下載了發表的359篇與SGA相關之原始文件。其中29.53%的文章與SGA臨床療效有關,40.11%的文章描述SGA的副作用。我們的研究結果符合Price定律,亦即與雙極性疾患有關的文章數呈現指數性的成長(r=0.960,線性校正後r = 0.931)。SGA最常被研究的藥物分別為clozapine(89)、risperidone(82)、aripiprazole(74)、olanzapine(62)及quetiapine(22)。利用Bradford定律的離散性分析得知,文章發表多集中在Progress in Neuro-Psychopharmacology and Biological Psychiatry期刊(56)。所有來自台灣的文章發表在90種不同期刊,而且在前10名最常發表的期刊中,有8種期刊的影響係數(impact factor)大於2。結論:台灣所發表的SGA之文章數量,在本研究的期間內呈現指數性的成長。
Background: This is a bibliometric study on the scientific papers of second generation (atypical) antipsychotic drugs (SGAs) from Taiwan. Methods: With the EMBASE and MEDLINE databases, we chose the published documents from Taiwan with the descriptors of atypical*, antipsychotic*, second-generation antipsychotic*, clozapine, risperidone, olanzapine, ziprasidone, quetiapine, sertindole, aripiprazole, paliperidone, amisulpride, zotepine, asenapine, iloperidone and lurasidone. We used bibliometric indicators of production and dispersion, i.e., Price's law on the increased scientific papers, and Bradford's law on dispersion. We also calculated the participation index of the different countries, and correlated those bibliometric data with some social and health data from Taiwan (such as total per capita expenditure on health and overall volume of production in the field of Psychiatry and Neurology). Results: We downloaded 359 SGA-related original documents published from 1993 to 2011:29.53% of them were dealt with clinical efficacy and 40.11% tolerance and safety. Our study results fulfilled Price's law, that scientific SGA papers showed exponential growth (r = 0.9601, as against an r = 0.9305 after linear adjustment). OfSGA publications, the drugs most studied are clozapine (89 papers), risperidone (82), aripiprazole (74), olanzapine (62), and quetiapine (22). Division of the results into Bradford zones yielded a nucleus published exclusively in the Progress in Neuro-Psychopharmacology and Bio logical Psychiatry (56 articles). All papers from Taiwan were published in 90 different journals, and 8 of the first 10 most often published journals for Taiwanese papers have an impact factor being greater than 2. Conclusion: The published SGA papers from Taiwan have been growing exponentially from 1933-2011, without any evidence of reaching a saturation point.
期刊論文
1.Shen, Winston W.(1999)。A history of antipsychotic drug development。Comprehensive Psychiatry,40(6),407-414。  new window
2.白雅美(20120300)。Pharmacological Studies on Patients with Schizophrenia in Taiwan: A Compilation of Literature。Taiwanese Journal of Psychiatry,26(1),6-18+66。new window  new window
3.Pritchard, Alan(1969)。Statistical bibliography or bibliometrics?。Journal of Documentation,25(4),348-349。  new window
4.Goldner EM、Hsu L、Waraich P、Somers JM(2002)。Prevalence and incidence studies of schizophrenia disorder: a systematic review of literature。Can J Psychiatry,47,833-843。  new window
5.Lehmann HE、Ban TA.(1997)。The history of the psychopharmacology of schizophrenia。Can J Psychiatry,42,152-163。  new window
6.Lopez-Munoz F、Alamo C、Cuenca E(2004)。La “Decada de Oro” de la psicofarmacologia (1950-1960): trascen- dencia historica de la introduction clinica de los psicofarmacos clasicos。Psiquiatria.COM(an electronic journal),4(3)。  new window
7.Ban TA(2001)。Pharmacotherapy of mental illness: a historical analysis。Prog Neuro-Psychopharmacol Biol Psychiatr,25,709-727。  new window
8.Lopez-Munoz F、Alamo C、Rubio G、Cuenca E(2004)。Half a century since the clinical introduction of chlor-promazine and the birth of modem psychopharmacology。Prog Neuro-Psychopharmacol Biol Psychiatr,28,205-208。  new window
9.López-Muñoz, Francisco、Alamo, Cecilio、Cuenca, Eduardo、Shen, Winston W.、Clervoy, Patrick、Rubio, Gabriel(2005)。History of the discovery and clinical introduction of chlorpromazine。Annals of Clinical Psychiatry,17(3),113-135。  new window
10.Lopez-Munoz F、Alamo C(2009)。The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice。Brain Res Bull,79,130-141。  new window
11.Kane J、Honigfeld G、Singer J、Meltzer H(1988)。Clozapine for the treatment-resistant schizophrenic。Arch Gen Psychiatry,45,780-796。  new window
12.Hippius H(1999)。A historical perspective of clozapine。J Clin Psychiatry,60 (Suppl. 12),22-23。  new window
13.Meltzer HY(2004)。What’s atypical about atypical antipsychotic drugs?。Curr Opin Pharmacol,4,53-57。  new window
14.Lopez-Munoz F、Alamo C:(2011)。Neurobiological background for the development of new drugs in schizophrenia。Clin Neuropharmacol,34,111-126。  new window
15.Bordons M、Zulueta MA(1999)。Evaluation de la actividad cientifica a traves de indicadores bibliometricos。Rev Esp Cardiol,52,790-800。  new window
16.White HD、McCain KW(1989)。Bibliometric。Ann Rev Inf Sci Technol,24,119-186。  new window
17.Lopez-Munoz F、Rubio G(1995)。La produccion cientffica espanola en psiquiatria: estudio bibliometrico de las publicaciones de circulacion internacional durante el periodo 1980-1993。An Psiquiatr,11,68-75。  new window
18.Lopez-Munoz F、Marin F, Boya J(1996)。Evaluation bibliometrica de la produccion cientifica espanola en neurociencia. Analisis de las publicaciones de difusion internacional durante el periodo 1984-1993。Rev Neurol,24,417-26。  new window
19.Lopez-Munoz F、Vieta E、Rubio G、Garcia-Garcia P、Alamo C(2006)。Bipolar disorder as an emerging pathology in the scientific literature: a bibliometric approach。J Affect Disord,92,161-170。  new window
20.Lopez-Munoz F、Alamo C、Quintero-Gutierrez FJ、Garcia-Garcia P(2008)。A bibliometric study of international scientific productivity in attention-deficit hyperactivity disorder covering the period 1980-2005。Eur Child Adolesc Psychiatry,17,381-391。  new window
21.Lopez-Munoz F、Garcia-Garcia P、Saiz-Ruiz J(2008)。A bibliometric study of the use of the classification and diagnostic systems in psychiatry over the last 25 years。Psychopathology,41,214-225。  new window
22.Lopez-Munoz F、Alamo C、Rubio G、Garcia-Garcia P、Martin-Agueda B、Cuenca E(2003)。Bibliometric analysis of biomedical publications on SSRIs during the period 1980-2000。Depress Anxiety,18,95-103。  new window
23.Garcia-Garcia P、Lopez-Munoz F、Rubio G、Martin-Agueda B、Alamo C(2008)。Phytotherapy and psychiatry: Bibliometric study of the scientific literature from the last 20 years。Phytomedicine,15,566-576。  new window
24.Lopez-Pinero JM、Terrada ML(1992)。Los indicadores bibliometricos y la evaluacion de la actividad medico-cientifica. III. Los indicadores de produccion, circulacion y dispersion, consumo de informacion y repercusion。Med Clin,98,142-148。  new window
25.Lopez-Pinero JM、Terrada ML(1992)。Los indicadores bibliometricos y la evaluation de la actividad medico-cientifica. IV. La aplicacion de los indicadores。Med Clin,98,384-388。  new window
26.Koskinen J、Isohanni M、Paajala H(2008)。How to use bibliometric methods in evaluation of scientific research? an example from Finnish schizophrenia research。Nordic J Psychiatry,62,136-143。  new window
27.Gomez I、Bordons M(1996)。Limitaciones en el uso de los indicadores bibliometricos para la evaluacion cientifica。Politico Cientifica,46,21-26。  new window
28.Fountoulakis KN、Nimatoudis I、Iacovides A、Kaprinis G(2004)。Off-label indications for atypical anti-psychotics: a systematic review。Ann Gen Hosp Psychiatr,3,4-14。  new window
29.Mortimer AM、Shepherd CJ、Rymer M、Burrows A(2005)。Primary care use of antipsychotic drugs: an audit and intervention study。Ann Gen Psychiatr,4,18-26。  new window
30.Clement S、Singh S、Burns T(2003)。Status of bipolar disor-der research。Br J Psychiatry,182,148-152。  new window
31.Theander SS、Wetterberg L(2010)。Schizophrenia in med-line 1950-2006: a bibliometric investigation。Schizophr Res,118,279-284。  new window
圖書
1.Shen, W. W.(2011)。Clinical Psychopharmacology for the 21st Century。Taipei:Hochi Publishing Company。  new window
2.Bradford, S. C.(1948)。Documentation。London:Crosby Lockwood & Son。  new window
3.Garfield, E.(1979)。Citation indexing - its theory and application in science, technology, and humanities。New York, NY:Institute of Scientific Information Press。  new window
4.de Solla Price, Derek J.(1963)。Little Science, Big Science。Columbia University Press。  new window
5.World Health Organization(2001)。Mental Health: New Understanding。New Hope. Geneva:WHO。  new window
其他
1.(2010)。Statistics Office: 2009 National Health Expenditure,Taipei:Department of Health, Executive Yuan。  new window
2.OECD Health Divisio(2011)。OECD Health Data 2011: Frecuently Requested Data,Paris:OECD。  new window
3.(2011)。World Health Organization Department of Health Statistics and Informatics: World Health Statistics 2011,Geneva:WHO。  new window
圖書論文
1.Lopez-Munoz F、Alamo C、Cuenca E(1998)。Farmacos an-tipsicoticos。Historia de la Neuropsicofarmacologia \\ Lopez-Munoz F ; Alamo C (eds.)。Madrid:Ediciones Eurobook S.L.。  new window
2.Alamo C、Cuenca E、Lopez-Munoz F、Garcla-Garcia P(2007)。Neurolepticos y antipsicoticos: aspectos farma-cologicos de la evolucion del tratamiento de la esquizofrenia。Nuevas Generaciones en Neurociencias. Las Esquizofrenias. Sus Hechos y Valores Clinicos y Terapeuticos \\ Chinchilla A (ed.)。Barcelona:Elsevier Masson。  new window
3.Lopez-Munoz F、Alamo C、Guerra JA、Rubio G(2006)。Twenty-four years of scientific publications on selective serotonin reuptake inhibitors (SSRI): a bibliometric approach。Focus on Serotonin Uptake Inhibitor Research \\ Shirley AC (ed.)。New York:Nova Science Publishers, Inc.。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE